We describe the effects of tissue preservation, fmtion time, and hydrolytic treatment on the detection of proliferating cell nuclear antigen (PCNA) by immunoperoxidase staining with three commercial anti-PCNA antibodies (19A2, l9F4, PClO). Our goal was to provide guidelines for PCNA immunohistochemistry in formalin-fued, paraffin-embedded specimens. In proliferative cell compartments, nudear staining was achieved with all three antibodies. In some cases PCNA was also expressed in non-proliferative, histologically normal tissues associated with tumors or other lesions elsewhere. In most autopsy specimens PNCA immunoreactivity was markedly diminished as compared with similar surgical specimens. Incubation overnight with primary antibody at 4°C enhanced PCNA immunoreactivity over incubation at 421C for 45 min. Pre-treatment with 2 N HCI did not increase staining. Staining with the PClO antibody was much better preserved than staining with the antibodies 19A2 and 19F4 after prolonged formalin fmtion of surgical specimens and in tissues obtained at autopsy. With all three antibodies, however, PCNA immunoreactivity was well preserved during formalin fmtion for 8-24 hr and during fmtion delays for 8 hr at room temperature. This indicates that PCNA is stable under conditions routinely encountered in diagnostic surgical pathology and facilitates its potential use as a diagnostic proliferation marker. ( J His-
Introduction
Proliferating cell nuclear antigen, a highly conserved auxiliary protein for the DNA polymerase 6, is greatly increased in proliferating cells as compared with mitotically quiescent cells (for review see 1.2). Immunohistochemical staining for PCNA accurately outlines proliferating cell compartments in various tissues (3) (4) (5) (6) (7) (8) . Recently, we have demonstrated a linear correlation between PCNA indices and S-phase fractions as determined by bromodeoxyuridine incorporation in regenerating liver (9). Good correlations have also been shown between PCNA indices and labeling with Ki-67, a monoclonal antibody that recognizes nuclei of proliferating cells (6,7,10). PCNA immunohistochemistry is a potentially valuable tool for defining proliferative activity in diagnostic pathology because, in contrast to staining with Ki-67, it can be performed on formalinfixed tissues (4,6-9,11), and it is independent of exogenous tracer molecules such as tritiated thymidine or bromodeoxyuridine. However, the detection of PCNA is greatly dependent on the tissue fixation, the antibodies, and the immunohistochemical techniques * Correspondence and present address: Helmut K. Wolf, MD, Institut fiir Neuropathologie, Universitaetskliniken Bonn, Sigmund-Freud-Str. 25, 5300 Bonn 1, Germany. that are utilized (4-7,12-14). Here we comprehensively evaluate how PCNA immunoreactivity with three commercial anti-PCNA antibodies is affected by various states of tissue preservation and fixation as they frequently occur in diagnostic pathology. Our goal was to provide guidelines for PCNA immunohistochemistry in formalin-fixed, paraffii-embedded surgical and autopsy specimens.
Materials and Methods
Tissues and Fixation. Generous samples of the following organs and tissues were obtained immediately after surgical rem&: histologically normal colon (two cases), spleen (two cases), kidney (two cases), and small intestine (two cases); liver with slight steatosis (one case), colon adenocarcinoma (two cases), renal cell carcinoma of clear-cell type (two cases), adenocarcinoma of breast (one case), and metastatic adenocarcinoma of the liver (one case). Each specimen was trisected. Two of the pieces were immediately placed in 10% neutral buffered formalin and fiied for 6 and 24 hr. respectively. The third piece was kept on saline-soaked gauze at room temperature for 8 hr and was then fixed in formalin for 24 hr. These conditions were chosen to match situations in diagnostic surgical pathology laboratories. For example, fixation may be delayed when specimens are submitted at night, or prolonged fixation may occur on weekends. To evaluate the effects of formalin fixation for extended periods of time, PCNA staining was performed on two representativc sections of small intestine, placenta, tonsils, and spleen from grossly and histologically normal portions of surgical resection specimens. One sample was fixed in formalin for approxi-
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mately 24 hr. The other sample was fixed for 2 weeks. Prostate tissue with and without carcinoma and fetal rat tissues which had been fixed in formalin for 6 and 12 months, respectively, were also examined. All fixations were performed at room temperature. After fixation, the tissues were processed routinely through graded alcohols and xylene into paraffin.
To evaluate PCNA staining in autopsy tissues, blocks of histologically normal mature and immature (fetal) tissues and Various tumors [carcinomas of the lung (two cases), stomach, prostate, liver, glioblastoma multiforme, medulloblastoma, adenomatous colon polyp] removed at autopsy were retrieved from our files and stained for PCNA. The post-mortem intervals ranged from 2-48 hr. All tissues from visceral organs had been fixed in neutral buffered formalin for 1-4 days (average 3 days). Brains had been fixed for 2 weeks.
Antibodies. PCNA immunohistochemistry was performed using the monoclonal murine anti-PCNA antibodies 19F4 (IgG1, kappa; Boehringer Mannheim Biochemicals, Indianapolis, IN) and 19/12 (IgM kappa; Coulter, Hialeah, FL) developed and characterized by Ogata et al. (15, 16) and PClO (IgGzA; Signet Laboratories, Dedham, MA) developed by Waseem and Lane (17) .
Immunohistochemistry. Sections were cut at 4 pm, mounted on slides coated with 3-aminopropyltriethoxysilane (Sigma; St Louis, MO), air-dried at room temperature, and heated on a 60'C hot plate for a few seconds until the paraffin melted. After deparaffinization and rinses in 100% and 95% ethanol, the slides were incubated in 2% hydrogen peroxide diluted in methanol for 7 min. rehydrated in 95% ethanol, and rinsed again in PBS. If performed, incubation of the sections in 2 N HCI for 30 min at room temperature and three subsequent washes in PBS were carried out at this point. This was followed by pre-incubation with 5 % blocking serum diluted in PBS for 30 min and incubation with primary antibody diluted in PBS containing 1% bovine serum albumin at 4'C overnight or at 4 2 T for 45 min. (For primary antibody concentration, see Results.) The sections were then incubated with a biotinylated horse anti-mouse IgG (for staining with 19F4 and PClO) or goat anti-mouse IgM (for staining with 19A2) (both from Vector Laboratories, Burlingame, CA), diluted 1:200 in PBS with 1% bovine serum albumin at 42°C for 20 minutes. This was followed by incubation with avidin DH-biotinylated horseradish peroxidase H complex (Vectastain Elite ABC Kit; Vector Laboratories, Burlingame, CA) for 20 min at 42'C according to the instructions of the manufacturer. All steps were followed by appropriate washes in PBS. Finally, the sections were developed in a substrate solution of 0.05 % diaminobenzidine tetrahydrochloride and 0.01% hydrogen peroxide in 0.0s M Tris-HC1, pH 7.6, for 3 min. washed, lightly counterstained with hematoxylin, dehydrated in ethanol, and mounted in Refrax Mounting Medium (Anatech; Battle Creek, MI). Control sections of representative tissues were prepared by substitution of the primary antibody with dilutions of normal mouse serum or omission of the primary antibody. As positive control tissue we used a section of regenerating rat liver in which a high cell proliferative activity had been documented by incorporation of bromodeoxyuridine as described previ-On representative specimens, immunostaining was repeated on different days to ensure the technical reproducibility of the staining results. Repeated immunostaining was also performed on specimens in which unexpected results were seen, e.g., cases with staining of normal, mitotically inactive cells and specimens in which staining was present with some but not all of the antibodies. In the latter case, staining was also performed with increased concentrations of primary antibodies. ously (9) .
Evaluation. The distribution of PCNA staining was compared with the known localization of mitotically active (intestinal crypts, germinal centers of lymphoid tissues, malignant neoplasms with many mitotic figures) or quiescent cell populations (neurons, myocytes, normal hepatocytes). The staining intensity on each slide was graded semiquantitatively as follows: 0, no staining; 1, weak staining (positive nuclei were visible only at higher magnification); 2, intermediate staining; 3, strong staining (positive nuclei were visible at scanning power). We directly compared all tissue sections that had been obtained from a single primary specimen with regard to obvious changes in the relative numbers of PCNA-positive cells due to d&rent fixation and staining protocols. Because of the diversity and heterogeneity of the individual samples, we did not determine numeric labeling indices. A total of approximately 700 tissue sections were evaluated.
Staining Pattern
PCNA immunoreactivity was largely confined to nuclei of the proliferating cell populations (Figures 1-3) . Cytoplasmic staining was seen in many mitotic cells and in an occasional non-mitotic cell. The nuclear staining was granular and diffuse. There was no staining of nucleoli. There was a continuous spectrum of staining intensities. In tissues with strong PCNA immunoreactivity (Grade 3) there were nuclei with intense, intermediate, and weak staining. In some specimens only weak nuclear staining was present (Grade 1). Mitotically inactive cells such as neurons or myocytes were usually PCNA negative. However, unexpected nuclear staining of mitotically quiescent stromal and/or epithelial cells was observed in some specimens in conjunction with adjacent tumors or other lesions, such as in two cases of renal-cell carcinoma ( Figure  4) , a colon adenocarcinoma, chronic pancreatitis, and a case of small intestinal obstruction.
Selection of Primary Antibody
In tissues fixed for u p to 24 hr the optimal dilutions of the commercial primary antibody preparations and the corresponding antibody concentrations were as follows: 19F4, 1:150,6.7 pg/ml; 19A2, 1:1600, 12.5 pg/ml; PC10, 1:100,0.25 pglml. With these dilutions there was intense staining of nuclei in proliferating cell populations, with minimal background staining. Staining was usually more intense with the antibody PClO than with l9F4 or 19A2. Significantly greater concentrations of the primary antibodies resulted in increased cytoplasmic background staining and in faint diffuse nuclear staining of some non-mitotic cells. Background staining was more difficult to eliminate with the antibody l9A2 (IgM) than with the other antibodies. With all three antibodies, PCNA detection was enhanced when sections were incubated with the primary antibody overnight at 4°C as compared with incubation a t 42°C for 45 min. With all three antibodies the staining results were consistent with respect to distribution and intensity of PCNA immunoreactivity if staining was performed at different days on the same specimen.
Acid HydrolyJiJ
With all three antibodies, immunostaining was performed on sections from all tissue blocks with and without acid hydrolysis. N o significant changes in PCNA immunoreactivity were observed between sections treated with hydrochloric acid and sections in which this step had been omitted. ,G. 
Tissue Preservation and Fixation
With all three primary antibodies there were no notable differences in PCNA immunoreactivity between fixation in formalin for 6 and 24 hr. respectively (Figure 1) . Similarly, delaying fixation for 8 hr at room temperature did not noticeably diminish PCNA immunoreactivity (Figure 1) . In contrast, formalin fixation for several weeks or months resulted in a marked loss of PCNA immunoreactivity with the antibodies 19F4 and 19A2. In some of the tissues fixed for such extended periods of time, we were able to obtain some PCNA staining with increased concentrations of these primary antibodies (l9F4, 1:50; 19A2. 1:400). With the antibody PClO the loss of PCNA immunoreactivity during prolonged formalin fixation was less pronounced. Even after fixation for up to 12 months some staining was detectable (Figures 2 and 3) .
Notable loss in staining intensity due to prolonged fivation was associated with an obvious decrease in the numbers of PCNApositive cells. This was primarily due to a complete loss of PCNA positivity in the cell populations that had been only weakly positive under optimal conditions. Fixation for up to 24 hr and delaying fixation for 8 hr did not result in a discernible decrease in labeled cells.
In most autopsy specimens PCNA staining was markedly reduced as compared with that of similar surgical specimens. This loss of immunoreactivity, again, was most pronounced with the antibodies 19A2 and l9F4, which in most of the specimens did not reveal any significant staining for PCNA even when the primary antibodies were applied at increased concentrations. In some autopsy specimens, however, no PCNA staining was observed with any of the antibodies. There was no consistent relationship between this loss of staining and post-mortem intervals and PCNA staining. For example, no PCNA staining was detected in a squamous carcinoma of the lung and an adenocarcinoma of the prostate obtained within 2 hr after death, but moderate to strong PCNA immunoreactivity was present in another case after a post-mortem interval of 18 hr.
Discussion
The relevance of a new proliferation marker for diagnostic histo- pathology depends largely on its applicability to routinely prepared, paraffin-embedded tissues. Antibodies that can be used only on frozen sections (e.g.$ Ki-67) or after fixation with non-cross-linking fmtives. and others that recognize exogenous and potentially harmful tracer molecules (e.g., bromodeoxyuridine), are limited in their clinical use and preclude retrospective studies of archival material. In addition, a suitable proliferation marker should produce reliable results under various conditions of tissue preservation and fixation as they are encountered in diagnostic laboratories.
Our results show that tissue immunoreactivity with all three anti-PCNA antibodies is preserved by fmtion in formalin for time periods ranging from 6-24 hr, independent of the antibody used. The vast majority of the surgical specimens that are examined in our pathology laboratory are fixed within this time frame. Fixation delays for 8 hr, which occasionally occur when specimens are obtained during the night, did not significantly alter PCNA staining. This is consistent with the long half-life of PCNA of approximately 20 hr (13). The preservation of PCNA during formalin fixation for 24 hr and fixation delays for 8 hr at room temperature are desirable qualities for a potential diagnostic application.
The decrease of PCNA staining after formalin fixation for several weeks or months was much more pronounced with the antibodies 19F4 and 19A2 than with PC10. This indicates that the epitope recognized by PC10 is more resistant to formalin fixation than the epitopes recognized by 19A2 and l9F4, which are located on closely related sites in the center of the PCNA molecule (15J6). Although all three antibodies gave reproducible staining results with fixation times between 6-24 hr, PClO seems to be the prefera- ble antibody to evaluate PCNA expression after prolonged formalin fixation.
Galand and Degraef (4) described markedly increased PCNA immunoreactivity in formalin-fixed tissues when the sections were treated with 2 N HCI before application of the primary antibody (19A2). Other investigators have reported satisfactory results without HCI pre-treatment (6,7,11,18,19) . To address this discrepancy, we systematically compared PCNA immunoreactivity with and without HCI treatment in otherwise identical staining procedures on 56 different specimens from a variety of organs, including a number of fetal rat tissues. With all three antibodies the staining intensities with and without acid were virtually identical. These results indicate that acid pre-treatment is not necessary to detect PCNA in formalin-fixed tissues.
In contrast to the relatively stable expression of PCNA in surgical specimens, PCNA staining was often greatly diminished or absent in autopsy specimens, even after short post-mortem intervals of several hours. It is possible that the degradation of PCNA is expedited by agonal metabolic changes which may vary from case to case and are absent in surgical and biopsy material. We conclude that the evaluation of cell proliferation by PCNA immunohistochemistry is less reliable in autopsy than in surgical specimens.
In some cases there was markedly increased expression of PCNA in histologically normal tissues associated with tumors and other pathological conditions such as intestinal obstruction or chronic pancreatitis (Figure 4) . A similar dramatic increase of PCNA expression has previously been reported in normal tissues adjacent to pancreatic adenocarcinomas, islet cell tumors, and carcinomas of the breast (6) . In addition, PCNA-positive cells have been found outside the regenerative zones in normal gastric glands associated with benign cysts of the stomach (20) . Under normal conditions, PCNA expression appears to be limited to cells in proliferating tissue compartments; however, these findings suggest that in non-proliferating cells PCNA is expressed in response to injury. To clarify the significance of these findings, additional studies are necessary as new tools for the retrospective evaluation of cell proliferation in archival tissue blocks become available.
